Statistics

Total Visits

Views
Faldaprevir plus pegylated interferon alfa-2A and ribavirin in chronic HCV genotype-1 treatment-naive patients: Final results from startverso1, a randomised, double-blind, placebo-controlled phase III trial23

Select a period of time:

Number of views in the range

Views
Faldaprevir plus pegylated interferon alfa-2A and ribavirin in chronic HCV genotype-1 treatment-naive patients: Final results from startverso1, a randomised, double-blind, placebo-controlled phase III trial15

Views

Views
October 20240
November 20241
December 20241
January 20250
February 20250
March 202513
April 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore13
United Kingdom1
United States1
 

Top cities views

Views
Los Angeles1